GlassScriptPhysician profile
April D Ollis
NPI 1811294341
$5,047.05
in general payments reported to CMS, 2019-2025
33 companies · $1,237 in 2025
The $1,237 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $600 · 2022: $1,015 · 2023: $1,245 · 2024: $951 · 2025: $1,237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,432.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $883.78 | 2021-2025 | |
| Novo Nordisk INC | $588.41 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $488.37 | 2021-2025 | Farxiga, Airsupra |
| Amgen INC. | $480.75 | 2021-2025 | Otezla, Repatha, Repatha |
| Lilly USA, LLC | $352.05 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $339.57 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $323.30 | 2021-2025 | |
| Glaxosmithkline, LLC. | $280.47 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $180.35 | 2021-2024 | Synjardy, Ofev, Jardiance |
| Bausch Health US, LLC | $126.96 | 2021-2022 | |
| Astellas Pharma US INC | $99.63 | 2022-2025 | Veozah |
| Esperion Therapeutics, INC. | $96.26 | 2021-2022 | |
| Exact Sciences Corporation | $79.08 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lundbeck LLC | $74.29 | 2023-2025 | Vyepti, Rexulti |
| Horizon Therapeutics Plc | $70.10 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $68.31 | 2022 | |
| Axsome Therapeutics, INC. | $65.28 | 2024-2025 | Auvelity |
| Novartis Pharmaceuticals Corporation | $60.75 | 2022-2023 | |
| Daiichi Sankyo INC. | $55.12 | 2024-2025 | Injectafer |
| Merck Sharp & Dohme LLC | $43.53 | 2022 | |
| Janssen Pharmaceuticals, INC | $40.87 | 2021-2023 | Xarelto |
| Xeris Pharmaceuticals, INC. | $38.32 | 2025 | Gvoke Hypopen |
| Corium, LLC | $35.76 | 2023 | Adlarity |
| Biohaven Pharmaceuticals, INC. | $34.84 | 2021 | |
| Idorsia Pharmaceuticals US INC | $21.50 | 2022 | |
| Dexcom, INC. | $20.86 | 2024 | Dexcom G6 Transmitter |
| Philips North America LLC | $19.33 | 2024 | (Ck7) Extended Holter |
| Mayne Pharma Commercial LLC | $16.72 | 2022 | |
| Boston Scientific Corporation | $15.46 | 2024 | |
| Nevro Corp. | $14.78 | 2023 | Senza |
| Takeda Pharmaceuticals U.S.A., INC. | $12.78 | 2021 | |
| Currax Pharmaceuticals LLC | $12.06 | 2022 | |
| Phathom Pharmaceuticals, INC. | $7.41 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Ollis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.